[聚德沙用于中耳疾病的临床试验] - Suppr | 超能文献

[Clinical trial of polydexa in middle ear diseases].

作者信息

Martin H, Martin C

出版信息

JFORL J Fr Otorhinolaryngol Audiophonol Chir Maxillofac. 1975 Feb;24(2):157-61.

Abstract

摘要

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

文档翻译

学术文献翻译模型，支持多种主流文档格式。

相似文献

1

[Clinical trial of polydexa in middle ear diseases].[聚德沙用于中耳疾病的临床试验]

JFORL J Fr Otorhinolaryngol Audiophonol Chir Maxillofac. 1975 Feb;24(2):157-61.

2

[Use of Polydexa ear drops in E.N.T].[聚德沙星耳滴剂在耳鼻喉科的应用]

Ann Otolaryngol Chir Cervicofac. 1974 Jun;91(6):347-56.

3

[Clinical trial of Polydexa ear drops in otology (apropos of 30 cases)].聚德沙星滴耳液在耳科学中的临床试验（基于30例病例）

Rev Laryngol Otol Rhinol (Bord). 1975 Sep-Oct;96(9-10):559-61.

4

[Treatment of some inflammatory disorders of the ear with an association of fluocinolone acetonide, polymyxin B and neomycin].[用醋酸氟轻松、多粘菌素B和新霉素联合治疗耳部某些炎症性疾病]

Boll Mal Orecch Gola Naso. 1970;88(1):65-77.

5

[On the topical action of a new association (fluocinolone acetonide-antibiotics) in some external ear diseases].[关于一种新组合（曲安奈德 - 抗生素）在某些耳部疾病中的局部作用]

Arch Ital Otol Rinol Laringol Patol Cervicofacc. 1967 Sep-Oct;78(5):647-57.

6

[Therapy with Incut ear drops].[使用Incut耳滴剂进行治疗]

Hippokrates. 1968 Dec 15;39(23):898-900.

7

[Clinical trial of a new anti-inflammatory and anti-infectious otologic drugs: stapolidex].一种新型抗炎抗感染耳科药物：斯塔波利多克斯的临床试验

J Fr Otorhinolaryngol Audiophonol Chir Maxillofac (1967). 1970 May;19(5):415-6.

8

[The use of antibiotics in otologic practice].[抗生素在耳科临床实践中的应用]

Z Arztl Fortbild (Jena). 1969 Apr 1;63(7):361-4.

9

Ototoxicity of ear drops in patients suffering from chronic otitis media.慢性中耳炎患者中耳滴耳剂的耳毒性

J Laryngol Otol. 1989 Jan;103(1):46-50. doi: 10.1017/s0022215100108011.

10

[Ear drops otofa and polydexa for treatment of acute external otitis media in children].用于治疗儿童急性外耳道炎的耳滴剂otofa和polydexa

Vestn Otorinolaringol. 2003(3):53-4.

引用本文的文献

1

Systemic corticosteroids for acute otitis media in children.儿童急性中耳炎的全身性皮质类固醇治疗

Cochrane Database Syst Rev. 2018 Mar 15;3(3):CD012289. doi: 10.1002/14651858.CD012289.pub2.